Multi-layered cellulose nanocrystal system for CD44 receptor-positive tumor-targeted anticancer drug delivery

被引:39
作者
Seo, Ji-Hye [1 ]
Lee, Song Yi [1 ,2 ]
Hwang, ChaeRim [1 ]
Yang, Mingyu [1 ]
Lee, Junmin [3 ,4 ]
Lee, Seung-Hwan [5 ]
Cho, Hyun-Jong [1 ]
机构
[1] Kangwon Natl Univ, Coll Pharm, Chunchon 24341, Gangwon, South Korea
[2] Kangwon Natl Univ, Kangwon Inst Inclus Technol, Chunchon 24341, Gangwon, South Korea
[3] Univ Calif Los Angeles, Henry Samueli Sch Engn & Appl Sci, Dept Bioengn, Los Angeles, CA 90095 USA
[4] Univ Calif Los Angeles, Ctr Minimally Invas Therapeut C MIT, Los Angeles, CA 90095 USA
[5] Kangwon Natl Univ, Coll Forest & Environm Sci, Chunchon 24341, Gangwon, South Korea
基金
新加坡国家研究基金会;
关键词
Cellulose nanocrystal; Doxorubicin; Hyaluronic acid; CHONDROITIN SULFATE; NANOPARTICLES; DOXORUBICIN; THERAPY; NANOSTRUCTURES; IMPACT;
D O I
10.1016/j.ijbiomac.2020.06.193
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Layer-by-layer approach based on the electrostatic interactions has been introduced to make multi-layered targeting ligand-chemotherapeutics-cellulose nanocrystal (CNC) structure for tumor-targeted drug delivery. Negatively charged CNC was covered with cationic doxorubicin (DOX) molecule (as a chemotherapeutic agent) to fabricate DOX@CNC and sequentially wrapped with anionic hyaluronic acid (HA) polymer (as a CD44 receptor targeting ligand). Rod-shaped HA-coated DOX@CNC (HA@DOX@CNC) has been successfully fabricated and it exhibited 327 nm length, 12 nm width, -38 mV zeta potential, and 3% DOX content. HA@DOX@ CNC displayed higher cellular accumulation efficiency and antiproliferation potentials in CD44 receptor-positive lung adenocarcinoma (A549) cells compared to DOX and DOX-wrapped CNC (DOX@CNC). In A549 spheroid model, HA@DOX@CNC group exhibited superior tumor penetration capability, reactive oxygen species (ROS) production level, and cancer cell killing capacity rather than DOX and DOX@CNC group. In A549 tumor implanted mouse model, Cy5.5-labeled HA@DOX@CNC group exhibited higher tumor accumulation efficiency rather than free Cy5.5 after intravenous injection. All these findings suggest that designed HA@DOX@CNC can be one of promising biocompatible tumor-targeted nano-size drug delivery systems. (C) 2020 Elsevier B.V. All rights reserved.
引用
收藏
页码:798 / 809
页数:12
相关论文
共 51 条
[1]   Influence of doxorubicin on model cell membrane properties: insights from in vitro and in silico studies [J].
Alves, Ana Catarina ;
Magarkar, Aniket ;
Horta, Miguel ;
Lima, Jose L. F. C. ;
Bunker, Alex ;
Nunes, Claudia ;
Reis, Salette .
SCIENTIFIC REPORTS, 2017, 7
[2]   Cancer nanotechnology: The impact of passive and active targeting in the era of modern cancer biology [J].
Bertrand, Nicolas ;
Wu, Jun ;
Xu, Xiaoyang ;
Kamaly, Nazila ;
Farokhzad, Omid C. .
ADVANCED DRUG DELIVERY REVIEWS, 2014, 66 :2-25
[3]   Injectable Biocompatible Hydrogels from Cellulose Nanocrystals for Locally Targeted Sustained Drug Release [J].
Bertsch, Pascal ;
Schneider, Livia ;
Bovone, Giovanni ;
Tibbitt, Mark W. ;
Fischer, Peter ;
Gstoehl, Stefan .
ACS APPLIED MATERIALS & INTERFACES, 2019, 11 (42) :38578-38585
[4]   DLS and zeta potential - What they are and what they are not? [J].
Bhattacharjee, Sourav .
JOURNAL OF CONTROLLED RELEASE, 2016, 235 :337-351
[5]   Recent advances in physiologically based pharmacokinetic and pharmacodynamic models for anticancer nanomedicines [J].
Byun, Jong Hyuk ;
Han, Dong-Gyun ;
Cho, Hyun-Jong ;
Yoon, In-Soo ;
Jung, Il Hyo .
ARCHIVES OF PHARMACAL RESEARCH, 2020, 43 (01) :80-99
[6]   Doxorubicin: nanotechnological overviews from bench to bedside [J].
Cagel, Maximiliano ;
Grotz, Estefania ;
Bernabeu, Ezequiel ;
Moretton, Marcela A. ;
Chiappetta, Diego A. .
DRUG DISCOVERY TODAY, 2017, 22 (02) :270-281
[7]   Doxorubicin: The Good, the Bad and the Ugly Effect [J].
Carvalho, Cristina ;
Santos, Renato X. ;
Cardoso, Susana ;
Correia, Sonia ;
Oliveira, Paulo J. ;
Santos, Maria S. ;
Moreira, Paula I. .
CURRENT MEDICINAL CHEMISTRY, 2009, 16 (25) :3267-3285
[9]   Polyethylene glycol-conjugated hyaluronic acid-ceramide self-assembled nanoparticles for targeted delivery of doxorubicin [J].
Cho, Hyun-Jong ;
Yoon, In-Soo ;
Yoon, Hong Yeol ;
Koo, Heebeom ;
Jin, Yu-Jin ;
Ko, Seung-Hak ;
Shim, Jae-Seong ;
Kim, Kwangmeyung ;
Kwon, Ick Chan ;
Kim, Dae-Duk .
BIOMATERIALS, 2012, 33 (04) :1190-1200
[10]   To exploit the tumor microenvironment: Passive and active tumor targeting of nanocarriers for anti-cancer drug delivery [J].
Danhier, Fabienne ;
Feron, Olivier ;
Preat, Veronique .
JOURNAL OF CONTROLLED RELEASE, 2010, 148 (02) :135-146